Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
66,421,541
-
Share change
-
+90,347
-
Total reported value
-
$8,192,565,192
-
Put/Call ratio
-
56%
-
Price per share
-
$123.35
-
Number of holders
-
307
-
Value change
-
+$46,268,338
-
Number of buys
-
152
-
Number of sells
-
170
Institutional Holders of SALIX PHARMACEUTICALS INC - COM (SLXP) as of Q2 2014
As of 30 Jun 2014,
SALIX PHARMACEUTICALS INC - COM (SLXP) was held by
307 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,421,541 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT CO LLP, FMR LLC, VANGUARD GROUP INC, Viking Global Investors LP, BlackRock Fund Advisors, TIAA CREF INVESTMENT MANAGEMENT LLC, Bank of New York Mellon Corp, State Street Corp, Visium Asset Management, LP, and BlackRock Institutional Trust Company, N.A..
This page lists
307
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.